Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM)

CUSIP: G6333L200

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, $0.01 par value per share
Shares outstanding
28,961,082
Total 13F shares
2,279,287
Share change
+1,252,367
Total reported value
$2,267,892
Price per share
$1.00
Number of holders
18
Value change
+$1,239,828
Number of buys
8
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G6333L200?
CUSIP G6333L200 identifies ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q2 2025

As of 30 Jun 2025, Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,279,287 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Squarepoint Ops LLC, SABBY MANAGEMENT, LLC, New Leaf Venture Partners, L.L.C., Apollon Financial, LLC, OneDigital Investment Advisors LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP, Sanctuary Advisors, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.